ECTRIMS 2016: An Overview of Key Outcomes MStranslate September 22, 2016 Conferences, ECTRIMS, Research, Social Media Each year, the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) holds the largest MS research meeting in the world. In 2016, this event was held in London, England, between...
The ‘Publish’ or ‘Perish’ Pressure of Research MStranslate September 15, 2016 Opinion 1 Comment The Funding Flaws of Research By Tahlia, B Sci (Hons), University of Melbourne The pressure that so many researchers feel to secure competitive grant funding is distracting them from their real job....
High-dose Biotin Clinical Trial Results MStranslate September 13, 2016 Biotin, Clinical Trials, Research, Treatments 1 Comment Research Summary: MD1003 (high-dose biotin) for the treatment of multiple sclerosis: A randomised, double-blind, placebo-controlled study The background Whilst many treatments are now available for...
New Studies Question Gene Mutation Link to MS MStranslate September 12, 2016 Genetics, Research The results of an MS genetic study published in Neuron earlier this year are now being called into question. You may remember that MStranslate did a summary on this article and interviewed the lead researcher,...
The Misdiagnosis of Multiple Sclerosis: A Study MStranslate September 1, 2016 Research A study has provided evidence to something that has been discussed anecdotally for quite some time - a diagnosis of multiple sclerosis (MS) is difficult to make and it's sometimes made incorrectly. The study...
Source Selection: The Importance of Disclosure MStranslate August 30, 2016 Understanding Science CONTENT AND CONTEXT Knowledge is power. Always get the best information. Find the right resources. You will have heard me say these things many times in MStranslate posts. When I write summaries...
MS: Many Stories – From the MStranslate Community MStranslate August 27, 2016 Community, MS: Many Stories 2 Comments As there is no universal experience of living with multiple sclerosis (MS), MStranslate has always placed a strong focus on sharing personal experiences of living with the condition. This commitment has lead...
MOMENTUM Phase II Trial Results MStranslate August 22, 2016 Clinical Trials, Fingolimod, Research The background Fingolimod was approved in 2010 and became the first oral drug for the treatment of relapsing-remitting MS (RRMS). It has proven to be beneficial for many people with MS and works by...
Null is Really Something MStranslate August 9, 2016 Understanding Science According to the dictionary, ‘null’ is defined as a non-existent or empty value or as something that has no force or meaning. Null is nothing. Well, almost nothing for, in science, null is really...
Multiple Sclerosis & Molecular Mimicry MStranslate August 3, 2016 Epstein-Barr virus, Understanding Science Environmental factors in MS - Infection We know that there is an environmental component to multiple sclerosis. We know that there is an immune component to multiple sclerosis. One common way of linking...
